Oncimmune Holdings plc (LON:ONC – Get Free Report)’s stock price traded down 17.7% during mid-day trading on Monday . The stock traded as low as GBX 18.10 ($0.24) and last traded at GBX 18.10 ($0.24). 117,187 shares were traded during trading, an increase of 22% from the average session volume of 96,160 shares. The stock had previously closed at GBX 22 ($0.29).
Oncimmune Stock Down 17.7 %
The company has a fifty day simple moving average of GBX 14.13 and a 200-day simple moving average of GBX 17.92. The company has a quick ratio of 0.63, a current ratio of 1.13 and a debt-to-equity ratio of 806.85. The firm has a market cap of £13.42 million, a P/E ratio of -703.33 and a beta of 1.19.
Oncimmune Company Profile
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Featured Stories
- Five stocks we like better than Oncimmune
- What is the Dogs of the Dow Strategy? Overview and Examples
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- 3 Ways To Invest In Coffee, Other Than Drinking It
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- What is a Low P/E Ratio and What Does it Tell Investors?
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
